Results 111 to 120 of about 12,456 (182)

Prevalence of AAS-Positive Samples at Drug Abuse Laboratory Sweden Between 2014 and 2023 and Sub-Study of Dual Use of AAS and Narcotics. [PDF]

Drug Test Anal
Bohlin KP, Villén T, Hopcraft O, Pohanka A, Ekström L.   +4 more
europepmc   +1 more source

Real-world data on the abuse potential of medications for the treatment of insomnia: a disproportionality analysis of the FAERS database. [PDF]

Front Pharmacol
Saskin P, McCall WV, Neubauer DN, Crucitti A, Perry B, Luyet PP, Jaziri R, Vaillant C.   +7 more
europepmc   +1 more source

Immunomodulatory effect of Cannabis root extract on inflammatory cascades via endocannabinoid system regulation. [PDF]

BMC Complement Med Ther
Jin HL, Yu GR, Jung H, Lee MS, Kim H, Lim DW, Park WH.   +6 more
europepmc   +1 more source

Cardiovascular manifestations in mast cell activation disease: key insights for cardiologists and angiologists. [PDF]

Front Cardiovasc Med
Taumann W, Molderings GJ.
europepmc   +1 more source

State Laws Banning Prior Authorization For Medications For Opioid Use Disorder Increased Substantially, 2015-23. [PDF]

Health Aff (Millwood)
Hu JC, Hutchings K, Jalali A, Kapadia SN, Bao Y, Underhill K.   +5 more
europepmc   +1 more source

Exploring Polypharmacy in the BC Correctional Health Setting. [PDF]

Can J Hosp Pharm
Lo L, Masson S, Brons M, Leung B.
europepmc   +1 more source

Effectiveness, acceptability, and feasibility of naloxone in carceral settings: a scoping review. [PDF]

Harm Reduct J
Ravichandran N, Cullen W, Van Hout MC, Smyth J, Crowley D.   +4 more
europepmc   +1 more source

G Protein Inactivation as a Mechanism for Addiction Treatment. [PDF]

Biol Psychiatry
Neiswanger C, Ruiz MV, Kimball K, Lee JD, Land BB, Berndt A, Chavkin C.   +6 more
europepmc   +1 more source

Paravertebral blocks and enhanced recovery after surgery protocols in breast reconstructive surgery: Patient selection and perspectives [PDF]

, 2018
Myckatyn, Terence M, Parikh, Rajiv P
core   +1 more source